Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  Zaidat, Osama O ^a   Lazzaro, Marc ^a   McGinley, Emily ^a   Edgell, Randall C ^b   Nguyen, Thanh ^c   Linfante, Italo ^d   Janjua, Nazli ^e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d Baptist Vascular Institute ^*  (United States)

^e Asia Pacific Comprehensive Stroke Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; DISEASE REGISTRY; ENDOVASCULAR THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL SPECIALIST; NEUROINTERVENTIONALIST; PERCUTANEOUS THROMBECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED STATES; ADULT; AGED; HEALTH CARE NEED; HEALTH CARE QUALITY; INCIDENCE; MEDICAL PERSONNEL; NONSURGICAL INVASIVE THERAPY; POPULATION DENSITY; TRAINING;

EID: 84867522554     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826957ef     Document Type: Article

References (30)

1. Ginsberg MD. The validity of rodent brain-ischemia models is self-evident. Arch Neurol 1996;53:1065-1066.
2. Del Zoppo GJ, Levy D, Broderick JP. Thrombolytic therapy in the treatment of stroke. Drugs 1997;54(suppl 3):90-99.
3. Saver JL. Time is brain: quantified. Stroke 2006;37:263-266.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
5. Ogawa A, Mori E, Minematsu K, et al; MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633-2639.
6. IMS II Trial Investigators. The International Management of Stroke (IMS) II Study. Stroke 2007;38:2127-2135.
7. Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke (THRACE). Available at: http://clinicaltrials.gov/ct2/ show/NCT01062698. Accessed February 2012.
8. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999;9:193-201.
9. Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusionweighted and perfusion MRI. Stroke 1999;30:2043-2052.
10. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion-and diffusionweighted MRI. Neurology 1998;51:418-426.
11. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-1072.
12. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215.
13. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics: 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480.
14. Lanska DJ. Geographic distribution of stroke mortality in the United States: 1939-1941 to 1979-1981. Neurology 1993;43:1839-1851.
15. Wolfe AP. Epidemiology of stroke. In: Mohr JP, Choi DW, Grotta JC. Stroke: Pathophysiology, Diagnosis, and Management, 4th ed. New York: Churchill Livingstone; 2004:13-34.
16. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke. Stroke 1998;29:4-11.
17. Smith WS, Sung G, Starkman S, et al, for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438.
18. Smith WS, Sung G, Saver J, et al., for the Multi MERCI investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI Trial. Stroke 2008;39:1205-1212.
19. The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-2768.
20. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015-1020.
21. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254-2258.
22. Michel P, Odier C, Rutgers M, et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke 2010;41:2491-2498.
23. Cloft HJ, Rabinstein A, Lanzino G, Kallmes DF. Intraarterial stroke therapy: an assessment of demand and available work force. AJNR Am J Neuroradiol 2009;30:453-458.
24. Hirsch JA, Yoo JA, Nogueira RG, et al. Case volume of intra-arterial and intravenous treatment of ischemic stroke in the USA. J NeuroInterv Surg 2009;1:27-31.
25. Suzuki S, Saver JL, Scott P, et al. Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am J Neuroradiol 2004;25:1802-1806.
26. Connors JJ 3rd, Sacks D, Furlan AJ, et al. NeuroVascular Coalition Writing Group: training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology. Neurology 2005;64:190-198.
27. Rosenfield K, Babb JD, Cates CU, et al. Clinical competence statement on carotid stenting: training and credentialing for carotid stenting: multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol 2005;45:165-174.
28. Meyers PM, Schumacher HC, Alexander MJ, et al; Writing Group for American Academy of Neurology, American Association of Neurological Surgeons Cerebrovascular Section, Society of Neurointerventional Surgery, and Society of Vascular and Interventional Neurology. Performance and training standards for endovascular ischemic stroke treatment. J Stroke Cerebrovasc Dis 2009;18:411-415.
29. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
30. Brinjikji W, Rabinstein AA, Kallmes DF, Cloft HJ. Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the National Inpatient Sample: 2006 to 2008. Stroke Epub 2011 Apr. 14.